StonvexLoading…
StonvexCore line items from REPX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $144.99M | $113.88M | $391.98M | $294.70M | $187.85M |
Operating Income | Not available | $43.67M | $133.28M | $107.12M | $78.26M |
Net Income | Not available | $-70.43M | $160.84M | $75.44M | $59.10M |
EPS (Diluted) | $1.39 | $-3.38 | $7.59 | $3.56 | $2.80 |
Total Assets | Not available | $1.18B | $1.17B | $1.19B | $1.03B |
Total Liabilities | Not available | $626.64M | $535.34M | $624.84M | $476.69M |
Cash & Equivalents | Not available | $15.81M | $17.89M | $16.46M | $14.03M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 20.87M | 21.72M | 22.01M | 22.05M |